TP53 and lung carcinoma: In lung cancer patients, the most frequently mutated genes were TP53 (53% patients), EGFR (23.5%), and KRAS (17.7%); in colorectal cancer, KRAS (80%), APC (80%), and TP53 (60%) (Table 3).